L-dopa and frontal cognitive function in Parkinson's disease.
Lange
K W
KW
Institute of Neurology, London, United Kingdom.
Paul
G M
GM
Robbins
T W
TW
Marsden
C D
CD
D000368:Aged; D003704:Dementia / Q000188:drug therapy* / Q000503:physiopathology; D005625:Frontal Lobe / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008606:Mental Processes / Q000187:drug effects / Q000502:physiology; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
D007980:Levodopa